Developer docs
API playgroundTry for free, no card

Search company profiles

Olea Medical

Full company profile

uuid0009u77

Namestring
Olea Medical
Legal namestring
Olea Medical
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Olea Medical, headquartered in La Ciotat, France, develops medical imaging post-processing software used by hospitals, diagnostic imaging centers, and radiology departments for MRI and CT scan analysis. Founded in 2008 and operating as a wholly-owned subsidiary of Canon Medical Systems Corporation, the company commercializes the Olea Sphere platform — an intelligent applications suite covering neurovascular emergency, neurology, cardiology, oncology, women's health, APT CEST molecular imaging, and functional MRI. The platform processes 3D/4D DICOM images and combines quantitative analytics, AI-driven anomaly detection, and automated reporting to support radiologist decision-making across multiple clinical specialties.

The technology stack is anchored on proprietary deep-learning models (e.g., iPE trained on 4,795+ cases for incidental pulmonary embolism detection) and multimodal MRI sequence analysis (T1, T2, FLAIR, DWI, SWI, pCASL, APTw). Olea generates revenue primarily through cloud-based SaaS subscriptions licensed to hospital and imaging-center enterprises under custom annual contracts, sold via a direct enterprise field-sales motion and distributed globally through the Canon Medical OEM network. A 2026 collaboration with QT Imaging Holdings extends distribution into an external cloud SaaS channel. The company employs 51-100 staff representing 17 nationalities and maintains an active hiring pipeline of approximately 50 open roles.

Short descriptiontext

Olea Medical develops AI-powered MRI and CT post-processing software under the Olea Sphere platform for hospitals, imaging centers, and radiologists across neurology, cardiology, oncology, and women's health specialties, distributed globally as a Canon Medical Systems subsidiary.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLa Ciotat, France
HQ citystring
La Ciotat
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical imaging software, MRI post-processing, radiology AI platform, CT diagnostic imaging, medical image analytics
Industry3 codes
PRIMARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI
NAICS code1 code
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services51821
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Software/SaaS Subscriptions
TypeSubscription Recurring
Description

Olea Medical operates as a SaaS-based medical imaging software company, delivering its Olea Sphere platform via cloud-based subscriptions to hospitals and imaging centers. Revenue is generated through recurring software subscription fees, likely structured per modality, site, or seat.

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Custom enterprise pricing based on facility configuration
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing is not publicly disclosed. The company uses a 'Request a Demo' sales motion, indicating enterprise-level custom pricing rather than standardized tiers.

GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1Olea Sphere
Description

Intelligent MRI and CT applications platform for optimal patient-centric care

olea-medical.com
+4 more records
Core offering1 text field

Olea Medical develops and commercializes Olea Sphere, an intelligent cloud-based post-processing software platform for MRI and CT medical imaging. The platform provides automated quantitative analysis, AI-ready imaging tools, and clinical decision support across neurology, cardiology, oncology, women's health, and neurovascular emergency care for radiologists, hospitals, and diagnostic imaging centers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Olea Medical develops and commercializes intelligent post-processing software for MRI and CT medical imaging under the Olea Sphere® platform. The company operates as a subsidiary of Canon Medical Systems Corporation and is headquartered in La Ciotat, France. The product portfolio includes a core platform (Olea Sphere®) with specialized clinical modules for Neurovascular Emergency, Neurology, Women's Health, Oncology, Cardiology, APT CEST imaging, and Functional MRI. The company also offers AI-powered solutions including iPE for incidental pulmonary embolism detection and the Off Search Findings product line for automated incidental findings detection. The platform integrates advanced 3D/4D DICOM viewing, quantitative analytics, and AI-ready imaging technologies to provide optimal patient-centric care.

Product and service4 records
1Olea Sphere
CategoryMedical Imaging Software Platform
Description

Comprehensive intelligent post-processing platform for MRI and CT medical imaging, providing optimal patient-centric care across multiple clinical specialties. Targets radiologists, hospitals, and diagnostic imaging centers needing automated post-processing and quantitative analysis.

2Neurovascular Emergency (Automation Platform V1.5)
CategoryAutomated Diagnostic Workflow Software
Description

Automated neurovascular emergency solution for ER departments providing intelligent case prioritization, real-time triage, automatic report generation, and instant delivery to radiologist work tools (mobile, email, PACS). Optimizes workload and management in emergency settings.

3iPE (incidental Pulmonary Embolism)
CategoryAI Diagnostic Detection Software
Description

AI-powered solution for automated detection of incidental pulmonary embolism in chest CT scans, using deep learning algorithms trained on over 4,795 cases to flag unexpected findings and accelerate clinical workflow.

4Off Search Findings
CategoryAutomated Incidental Findings Detection Software
Description

Product line within the automation platform designed to signal unexpected anomalies or other clinically relevant findings discovered incidentally during medical imaging analysis.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-01-01
Description

Olea Medical has a strategic collaboration with QT Imaging Holdings to integrate its advanced visualization, quantitative analytics, and AI-ready imaging technologies into QT Imaging's cloud-based SaaS platform. This partnership enhances the diagnostic capabilities available to healthcare providers by combining Olea Medical's post-processing expertise with QT Imaging's platform infrastructure.

Strategic tierFlagshipTypeOthers
Description

Canon Medical Systems Corporation is the parent company of Olea Medical. As a subsidiary, Olea Medical operates within the Canon Medical portfolio and benefits from its global distribution network, brand reputation, and integration with Canon imaging equipment.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Viz.ai develops AI-powered clinical decision and workflow software for medical imaging, notably for neurovascular emergencies (stroke triage). Directly comparable as a SaMD imaging AI vendor serving radiologists and hospitals with real-time, automated post-processing and notification workflows.

TypeDirect peer
Description

RapidAI provides AI-driven post-processing and decision-support software for CT and MRI in stroke, aneurysm, and other neurovascular/PE use cases. Highly comparable in target customer (radiology/hospitals), product (imaging post-processing SaaS), and clinical workflow automation approach.

TypeDirect peer
Description

Aidoc offers an AI platform for radiology that triages and flags acute findings across CT and MRI modalities, integrated with PACS workflows. Comparable as an enterprise SaaS medical imaging AI vendor selling to hospitals and imaging centers with workflow automation.

TypeDirect peer
Description

icometrix develops AI-based MRI post-processing software focused on neurology (multiple sclerosis, dementia, traumatic brain injury). Directly comparable as a specialty MRI AI SaMD vendor for quantitative neuroimaging analysis used by radiologists and clinical specialists.

TypeDirect peer
Description

Quibim provides AI-powered quantitative imaging biomarkers for MRI and CT across oncology, neurology, and musculoskeletal applications. Comparable multi-specialty imaging AI SaaS vendor targeting hospitals and clinical specialists.

TypeDirect peer
Description

HeartFlow offers AI-based cardiac imaging analysis (FFR-CT) for coronary disease assessment. Comparable as a clinical-decision-support SaMD vendor selling advanced cardiac imaging analytics to hospitals and cardiology specialists.

TypeEmerging player
Description

Perspectum develops AI-driven MRI analysis software for liver, prostate, and other organ-specific quantitative imaging. Comparable in delivering AI-based specialty MRI post-processing SaaS to clinical specialists, though with narrower organ coverage than Olea.

TypeEmerging player
Description

Subtle Medical provides AI-based MRI image enhancement and acceleration tools for radiology workflows. Comparable AI imaging vendor serving hospitals and imaging centers, though focused on image acquisition rather than post-processing analytics.

TypeEmerging player
Description

Blackford Analysis offers an AI platform that curates and deploys third-party imaging algorithms to radiology practices. Comparable in enabling multi-specialty imaging AI delivery in hospital settings, though positioned as a marketplace/platform rather than proprietary algorithms.

TypeEmerging player
Description

Arterys (acquired by Tempus) provides cloud-native AI imaging analytics for cardiac, lung, and other CT/MRI applications. Comparable cloud-based imaging AI SaaS vendor serving clinical specialists, now part of a larger precision medicine platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Olea Medical

Medical Imaging Softwareolea-medical.com

Olea Medical develops AI-powered MRI and CT post-processing software under the Olea Sphere platform for hospitals, imaging centers, and radiologists across neurology, cardiology, oncology, and women's health specialties, distributed globally as a Canon Medical Systems subsidiary.

What Olea Medical does

Olea Medical, headquartered in La Ciotat, France, develops medical imaging post-processing software used by hospitals, diagnostic imaging centers, and radiology departments for MRI and CT scan analysis. Founded in 2008 and operating as a wholly-owned subsidiary of Canon Medical Systems Corporation, the company commercializes the Olea Sphere platform — an intelligent applications suite covering neurovascular emergency, neurology, cardiology, oncology, women's health, APT CEST molecular imaging, and functional MRI. The platform processes 3D/4D DICOM images and combines quantitative analytics, AI-driven anomaly detection, and automated reporting to support radiologist decision-making across multiple clinical specialties.

The technology stack is anchored on proprietary deep-learning models (e.g., iPE trained on 4,795+ cases for incidental pulmonary embolism detection) and multimodal MRI sequence analysis (T1, T2, FLAIR, DWI, SWI, pCASL, APTw). Olea generates revenue primarily through cloud-based SaaS subscriptions licensed to hospital and imaging-center enterprises under custom annual contracts, sold via a direct enterprise field-sales motion and distributed globally through the Canon Medical OEM network. A 2026 collaboration with QT Imaging Holdings extends distribution into an external cloud SaaS channel. The company employs 51-100 staff representing 17 nationalities and maintains an active hiring pipeline of approximately 50 open roles.

Olea Medical firmographics

Firmographics
Name
Olea Medical
Legal name
Olea Medical
Website
https://olea-medical.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
101–250 employees
Short description
Olea Medical develops AI-powered MRI and CT post-processing software under the Olea Sphere platform for hospitals, imaging centers, and radiologists across neurology, cardiology, oncology, and women's health specialties, distributed globally as a Canon Medical Systems subsidiary.
Ownership category
akta.pro rank

Olea Medical industry classification

Industry
Product category
Medical Imaging Software
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI

Keywords

  • Medical imaging software
  • MRI post-processing
  • Radiology AI platform
  • CT diagnostic imaging
  • Medical image analytics

Where Olea Medical is headquartered

Location

Headquarters

HQ city
La Ciotat
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Olea Medical business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Software/SaaS Subscriptions: Olea Medical operates as a SaaS-based medical imaging software company, delivering its Olea Sphere platform via cloud-based subscriptions to hospitals and imaging centers. Revenue is generated through recurring software subscription fees, likely structured per modality, site, or seat.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualCustom enterprise pricing based on facility configuration

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Olea Medical product offering

Product offering

Core offering

Olea Medical develops and commercializes Olea Sphere, an intelligent cloud-based post-processing software platform for MRI and CT medical imaging. The platform provides automated quantitative analysis, AI-ready imaging tools, and clinical decision support across neurology, cardiology, oncology, women's health, and neurovascular emergency care for radiologists, hospitals, and diagnostic imaging centers.

Product overview

Olea Medical develops and commercializes intelligent post-processing software for MRI and CT medical imaging under the Olea Sphere® platform. The company operates as a subsidiary of Canon Medical Systems Corporation and is headquartered in La Ciotat, France. The product portfolio includes a core platform (Olea Sphere®) with specialized clinical modules for Neurovascular Emergency, Neurology, Women's Health, Oncology, Cardiology, APT CEST imaging, and Functional MRI. The company also offers AI-powered solutions including iPE for incidental pulmonary embolism detection and the Off Search Findings product line for automated incidental findings detection. The platform integrates advanced 3D/4D DICOM viewing, quantitative analytics, and AI-ready imaging technologies to provide optimal patient-centric care.

Differentiator

Problem solved

Functional benefit

Brands

  • Olea Sphere: Intelligent MRI and CT applications platform for optimal patient-centric care
  • Olea Flex
  • Olea Cares
  • Olea Medical Academy
  • QT Imaging Olea Vision

Products and services

  • Olea Sphere Comprehensive intelligent post-processing platform for MRI and CT medical imaging, providing optimal patient-centric care across multiple clinical specialties. Targets radiologists, hospitals, and diagnostic imaging centers needing automated post-processing and quantitative analysis.
  • Neurovascular Emergency (Automation Platform V1.5) Automated neurovascular emergency solution for ER departments providing intelligent case prioritization, real-time triage, automatic report generation, and instant delivery to radiologist work tools (mobile, email, PACS). Optimizes workload and management in emergency settings.
  • iPE (incidental Pulmonary Embolism) AI-powered solution for automated detection of incidental pulmonary embolism in chest CT scans, using deep learning algorithms trained on over 4,795 cases to flag unexpected findings and accelerate clinical workflow.
  • Off Search Findings Product line within the automation platform designed to signal unexpected anomalies or other clinically relevant findings discovered incidentally during medical imaging analysis.

Companies that use Olea Medical

Customer profile

Segments6 records

Ideal customer profiles2 records

Olea Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature4 records

Olea Medical partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and flagship.

  • QT Imaging HoldingscoreTechnology or Integration · 1 January 2026Olea Medical has a strategic collaboration with QT Imaging Holdings to integrate its advanced visualization, quantitative analytics, and AI-ready imaging technologies into QT Imaging's cloud-based SaaS platform. This partnership enhances the diagnostic capabilities available to healthcare providers by combining Olea Medical's post-processing expertise with QT Imaging's platform infrastructure.
  • Canon Medical Systems CorporationflagshipOthersCanon Medical Systems Corporation is the parent company of Olea Medical. As a subsidiary, Olea Medical operates within the Canon Medical portfolio and benefits from its global distribution network, brand reputation, and integration with Canon imaging equipment.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Olea Medical competitors and assessment

Company assessment

Direct peers

  • Viz.ai: Viz.ai develops AI-powered clinical decision and workflow software for medical imaging, notably for neurovascular emergencies (stroke triage). Directly comparable as a SaMD imaging AI vendor serving radiologists and hospitals with real-time, automated post-processing and notification workflows.
  • RapidAI: RapidAI provides AI-driven post-processing and decision-support software for CT and MRI in stroke, aneurysm, and other neurovascular/PE use cases. Highly comparable in target customer (radiology/hospitals), product (imaging post-processing SaaS), and clinical workflow automation approach.
  • Aidoc: Aidoc offers an AI platform for radiology that triages and flags acute findings across CT and MRI modalities, integrated with PACS workflows. Comparable as an enterprise SaaS medical imaging AI vendor selling to hospitals and imaging centers with workflow automation.
  • icometrix: icometrix develops AI-based MRI post-processing software focused on neurology (multiple sclerosis, dementia, traumatic brain injury). Directly comparable as a specialty MRI AI SaMD vendor for quantitative neuroimaging analysis used by radiologists and clinical specialists.
  • Quibim: Quibim provides AI-powered quantitative imaging biomarkers for MRI and CT across oncology, neurology, and musculoskeletal applications. Comparable multi-specialty imaging AI SaaS vendor targeting hospitals and clinical specialists.
  • HeartFlow: HeartFlow offers AI-based cardiac imaging analysis (FFR-CT) for coronary disease assessment. Comparable as a clinical-decision-support SaMD vendor selling advanced cardiac imaging analytics to hospitals and cardiology specialists.

Emerging players

  • Perspectum: Perspectum develops AI-driven MRI analysis software for liver, prostate, and other organ-specific quantitative imaging. Comparable in delivering AI-based specialty MRI post-processing SaaS to clinical specialists, though with narrower organ coverage than Olea.
  • Subtle Medical: Subtle Medical provides AI-based MRI image enhancement and acceleration tools for radiology workflows. Comparable AI imaging vendor serving hospitals and imaging centers, though focused on image acquisition rather than post-processing analytics.
  • Blackford Analysis: Blackford Analysis offers an AI platform that curates and deploys third-party imaging algorithms to radiology practices. Comparable in enabling multi-specialty imaging AI delivery in hospital settings, though positioned as a marketplace/platform rather than proprietary algorithms.
  • Arterys: Arterys (acquired by Tempus) provides cloud-native AI imaging analytics for cardiac, lung, and other CT/MRI applications. Comparable cloud-based imaging AI SaaS vendor serving clinical specialists, now part of a larger precision medicine platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Olea Medical social profiles

Digital presence

Olea Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Olea Medical leadership team

Management profile

Number of profiles

Profiles2 records

Olea Medical funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Olea Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Olea Medical

What does Olea Medical do?

Olea Medical develops and commercializes Olea Sphere, an intelligent cloud-based post-processing software platform for MRI and CT medical imaging. The platform provides automated quantitative analysis, AI-ready imaging tools, and clinical decision support across neurology, cardiology, oncology, women's health, and neurovascular emergency care for radiologists, hospitals, and diagnostic imaging centers.

Is Olea Medical a public or private company?

Olea Medical is a private company. It is classified as corporate owned and is currently operating.

When was Olea Medical founded?

Olea Medical was founded in 2008. It employs 101 to 250 people.

Where is Olea Medical based?

Olea Medical is headquartered in La Ciotat, France, in the Europe region.

How does Olea Medical make money?

One revenue line is on record: software/SaaS Subscriptions.

Who are Olea Medical's main competitors?

Direct peers on record are Viz.ai, RapidAI, Aidoc, icometrix, Quibim and HeartFlow. Emerging players are Perspectum, Subtle Medical, Blackford Analysis and Arterys.

Does Olea Medical have an API?

No public API is recorded for Olea Medical.

What industry is Olea Medical in?

Olea Medical's product category is Medical Imaging Software. Its primary akta.pro industry code is HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software, with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 51821 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MorningstarMedian Technologies Announces Formation of Strategic Review Committee and R&D Committee to Unlock Intrinsic Value and Accelerate Its eyonis® Pan-Cancer StrategyMedian Technologies' Board formed a Strategic Review Committee to evaluate structural and financial alternatives, including a potential iCRO separation and U.S. listing, and an R&D Committee to oversee scientific development. The review follows recent milestones, including FDA clearance for eyonis® LCS, a €50 million capital raise, and a €82.4 million iCRO backlog.MarketScreenerMedian Technologies And Olea Medical Enter Strategic Commercial Agreement To Expand U.S. Access To Eyonis LCS For AI-Powered Lung Cancer ScreeningMedian Technologies and Olea Medical have entered a strategic commercial agreement to expand access to Eyonis LCS, an AI-powered software for lung cancer screening, in the United States. This partnership aims to leverage Median's distribution capabilities to introduce Olea Medical's diagnostic technology to U.S. clinicians and biopharmaceutical companies.YahooCanon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer ScreeningMedian Technologies, through its subsidiary Eyonis Inc., has entered into a strategic commercial agreement with Olea Medical, a Canon Medical Systems company, to expand U.S. access to eyonis LCS, the first FDA-cleared AI-powered software designed for lung cancer detection and malignancy assessment on low-dose CT scans. Canon Medical Systems' established relationships with U.S. radiology providers and healthcare systems will be leveraged to commercialize the technology across the U.S., with potential expansion to Europe and other markets. Clinical trial data submitted to the FDA showed radiologists using eyonis LCS achieved 93.3% sensitivity and 92.4% specificity, reducing false-negative interpretations by 66% and false-positive interpretations by 68% compared to unaided readings.FinancialContent Business PageCanon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer ScreeningEyonis Inc., a Median Technologies company, has entered into a strategic commercial agreement with Olea Medical, a Canon Medical Systems company, to expand U.S. access to eyonis LCS, the first FDA-cleared AI-powered SaMD that combines both detection and diagnostic assessment of pulmonary nodules in lung cancer screening. Canon Medical Systems' established relationships with U.S. hospitals and imaging centers will give Olea Medical a channel to commercialize the technology, with the agreement also covering Europe and other mutually agreed markets. In the clinical study supporting FDA clearance, radiologists using eyonis LCS achieved 93.3% sensitivity (versus 80.3% without) and 92.4% specificity (versus 76.4% without), with 75% of radiologists improving diagnostic performance.GlobeNewswireCanon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer ScreeningMedian Technologies' subsidiary Eyonis has entered into a strategic commercial agreement with Olea Medical, a Canon Medical Systems company, to expand U.S. access to eyonis\u00ae LCS, the first FDA-cleared AI-powered software that both detects pulmonary nodules and assesses their malignancy risk on low-dose CT scans. The partnership leverages Olea Medical's existing relationships with radiology providers and healthcare systems, with the AI device demonstrating 93.3% sensitivity and 92.4% specificity in clinical trials submitted for FDA clearance. The agreement also covers Europe and other markets that may be mutually agreed upon over time, positioning the technology for broader global deployment in lung cancer screening programs.GlobeNewswireCanon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer ScreeningEyonis and Olea Medical signed a strategic agreement to expand U.S. access to eyonis LCS, an AI-powered lung cancer screening tool. The first FDA-cleared SaMD combines nodule detection with malignancy assessment, improving diagnostic performance. The deal also covers Europe and other markets.BioSpaceMedian Technologies and Olea Medical, a Canon Medical Systems Company, Partner to Advance Commercial Deployment of AI-Powered eyonis® LCS for Lung Cancer ScreeningMedian Technologies and Olea Medical, a subsidiary of Canon Medical Systems Corporation, signed a global strategic commercial agreement to jointly commercialize the AI-powered eyonis® Lung Cancer Screening (LCS) software. This partnership builds on the product's recent FDA clearance in February 2026 and CE marking in July 2026, aiming to accelerate adoption across the United States and Europe. The collaboration integrates Median's diagnostic AI with Olea Medical's imaging platform to expand access to early lung cancer detection.01netMedian Technologies and Olea Medical, a Canon Medical Systems Company, Partner to Advance Commercial Deployment of AI-Powered eyonis® LCS for Lung Cancer ScreeningMedian Technologies and Olea Medical, a subsidiary of Canon Medical Systems, have signed a global strategic commercial agreement to jointly commercialize the AI-powered eyonis® LCS for lung cancer screening. This partnership aims to accelerate market adoption across the United States and Europe following the product's recent FDA clearance and CE marking approvals.FinancialContent Business PageMedian Technologies and Olea Medical, a Canon Medical Systems Company, Partner to Advance Commercial Deployment of AI-Powered eyonis® LCS for Lung Cancer ScreeningMedian Technologies and Olea Medical, a subsidiary of Canon Medical Systems Corporation, have signed a global strategic commercial partnership to jointly commercialize eyonis® LCS, an AI-powered lung cancer screening software, across the United States and Europe. The agreement builds on regulatory milestones including FDA 510(k) clearance obtained in February 2026 and CE marking achieved in July 2026, positioning the companies to accelerate market adoption of the first AI-powered SaMD approved in both the USA and EU for lung cancer screening. The partnership complements Median's previously announced collaboration with Tempus AI as part of its multi-channel commercialization strategy leveraging Canon's CT imaging infrastructure and Olea's radiology platform integration capabilities.MorningstarMedian Technologies and Olea Medical, a Canon Medical Systems Company, Partner to Advance Commercial Deployment of AI-Powered eyonis® LCS for Lung Cancer ScreeningMedian Technologies and Olea Medical signed a global strategic commercial agreement to advance the commercial deployment of eyonis LCS for lung cancer screening. The partnership follows FDA 510(k) clearance in February 2026 and CE marking in July 2026, and will support sales across the US and Europe.